nelfinavir has been researched along with Carcinoma, Non-Small Cell Lung in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Besse, A; Besse, L; Driessen, C; Kraus, M; Tarantino, I | 1 |
| Das, M | 1 |
| Goyal, M; Gupta, V; Kulkarni, NS; Parvathaneni, V; Shukla, SK | 1 |
| He, F; Huang, Z; Wang, G; Xu, Z | 1 |
| Evans, TL; Friedberg, J; Hahn, SM; Kucharczuk, J; Langer, CJ; Lin, LL; Maity, AM; Mick, R; Prendergast, S; Pryma, D; Rengan, R; Rosen, MA; Sharkoski, T; Stevenson, JP | 1 |
| Dennis, PA; Gills, JJ; Hollander, MC; Kawabata, S; Lopiccolo, J; Mercado-Matos, JR; Wilson, W | 1 |
| Adachi, Y; Bandobashi, K; Ikezoe, T; Kobayashi, M; Koeffler, HP; Nishioka, C; Taguchi, H; Takeuchi, S; Takeuchi, T; Yang, Y | 1 |
1 trial(s) available for nelfinavir and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
A phase I trial of the HIV protease inhibitor nelfinavir with concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small cell lung cancer: a report of toxicities and clinical response.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Follow-Up Studies; HIV Protease Inhibitors; Humans; Lung Neoplasms; Male; Middle Aged; Nelfinavir; Neoplasm Staging; Phosphoinositide-3 Kinase Inhibitors; Tomography, X-Ray Computed | 2012 |
6 other study(ies) available for nelfinavir and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
The cytotoxic activity of carfilzomib together with nelfinavir is superior to the bortezomib/nelfinavir combination in non-small cell lung carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Bortezomib; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Humans; Lung Neoplasms; Multiple Myeloma; Nelfinavir; Proteasome Endopeptidase Complex; Proteasome Inhibitors | 2023 |
Nelfinavir with concurrent chemoradiotherapy in NSCLC.
Topics: Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Clinical Trials, Phase I as Topic; HIV Protease Inhibitors; Humans; Lung Neoplasms; Nelfinavir | 2019 |
Nanotechnology Based Repositioning of an Anti-Viral Drug for Non-Small Cell Lung Cancer (NSCLC).
Topics: Activating Transcription Factor 3; Anti-HIV Agents; Apoptosis; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Membrane Permeability; Cell Proliferation; Drug Compounding; Drug Liberation; Drug Repositioning; Drug Stability; Gene Expression Regulation; HIV Protease Inhibitors; Humans; Lung Neoplasms; Microtubule-Associated Proteins; Nanocapsules; Nanotechnology; Nelfinavir; Polylactic Acid-Polyglycolic Acid Copolymer | 2020 |
Nelfinavir restricts A549 cell growth by inhibiting STAT3 signaling.
Topics: A549 Cells; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Humans; Lung Neoplasms; Nelfinavir; STAT3 Transcription Factor | 2021 |
Synergistic effects of nelfinavir and bortezomib on proteotoxic death of NSCLC and multiple myeloma cells.
Topics: Activating Transcription Factor 3; Animals; Apoptosis; Boronic Acids; Bortezomib; Carcinoma, Non-Small-Cell Lung; Caspases; CCAAT-Enhancer-Binding Proteins; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Endoplasmic Reticulum Stress; Humans; Mice; Mice, Nude; Multiple Myeloma; Nelfinavir; Protease Inhibitors; Pyrazines; RNA Interference; RNA, Small Interfering; Transplantation, Heterologous | 2012 |
NFV, an HIV-1 protease inhibitor, induces growth arrest, reduced Akt signalling, apoptosis and docetaxel sensitisation in NSCLC cell lines.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Docetaxel; Down-Regulation; Drug Combinations; Glycogen Synthase Kinases; HIV Protease Inhibitors; Humans; Intracellular Signaling Peptides and Proteins; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nelfinavir; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; RNA, Small Interfering; Signal Transduction; Taxoids; Tumor Suppressor Protein p53 | 2006 |